Mounjaro® Weight Loss Injection in Malaysia
Mounjaro Malaysia or it’s alternative name, Tirzepatide is the latest weight loss injection, medically approved for Type 2 Diabetes and upon clinical research, it’s also effective for weight loss.
Mounjaro’s active ingredient, Tirzepatide mimics the action of two natural body hormones, GIP & GLP-1 receptor agonist. These helps to regulate blood sugar, slow digestion, and helps to reduce appetite.
Mounjaro is officially approved by National Pharmaceutical Regulatory Agency (NPRA).
Mounjaro is now available at Da Vinci Clinic, Malaysia’s leading skin clinic & aesthetic clinic in Kuala Lumpur offers Mounjaro treatment for weight loss and Type 2 diabetes management, providing safe, NPRA-approved treatment with professional care.
What is Mounjaro?
This weight loss injection that came in by storm in 2025, Mounjaro (Tirzepatide) is a once-weekly weight loss injection.
Specifically, for Type 2 diabetes, however, Mounjaro contains Tirzepatide, a dual-action medication that releases GIP & GLP-1 receptor agonist. These helps to improve blood sugar control, slows digestion, improve insulin response, and reduce appetite.
Mounjaro is an approved weight loss medication under the brand name, Zepbound, commonly promotes long-term weight loss.
Mounjaro (Tirzepatide) Ingredient Explained
Mounjaro Malaysia or Tirzepatide, contains a dual-action ingredient that mimics two natural gut hormones typically found in the body: GIP & GLP-1
How Mounjaro Works? (Dual-Action GIP & GLP-1 Mechanism)
We have similar weight loss injection that focuses on GLP-1 receptor agonist, such as Wegovy and Ozempic. But they do not have the dual GIP + GLP-1 action like Mounjaro does. On the other hand, Mounjaro contains Tirzepatide, a dual-action GIP & GLP-1 receptor agonist.
These hormones help to regulate blood sugar, appetite, and feelings of fullness. Simpler terms, Ozempic & Wegovy are single-hormone mimickers (GLP-1), while Mounjaro is a dual-hormone mimicker (GIP + GLP-1).
To understand this mechanism in more detail, read our guide on Difference between GIP vs GLP-1 and how Mounjaro works differently from GLP-1 injections.
Is Mounjaro Safe to Use?
Mounjaro is a FDA-approved Type 2 Diabetes medication. Due to the great response of weight reduction, Mounjaro is widely used as weight loss treatment for weight management.
Real Results for Mounjaro
Before & After Images
Notes
Results shown are individual to each patient. A medical consultation is required to assess suitability and design a safe, supervised weight-management plan.
Mounjaro® (Tirzepatide) Results and Benefits
Mounjaro (Tirzepatide) dual-action medication, GIP & GLP-1 receptor agonist has shown significant results when used for anti-obesity weight management.
For suitable patients, Mounjaro supports weight management by helping regulate apptite, improve fullness, and support better metabolic control. It’s not deisgned to be a “quick-fix slimming injection” and should be used as part of a medically supervised programme.
Benefits of Tirzepatide:
- Controlling Blood Sugar Levels
Helps the body manage sugar levels more steadily after meals - Reduced Appetite
Patients feel less hungry and more in control of cravings - Slows Digestion
Helps food move slower through the stomach, so you feel full longer - Improve Insulin Response
Helps body to release insulin more effectively when blood sugar rises - Doctor-guided metabolic care
At Da Vinci Clinic, treatment is personalised based on your BMI, medical history, current medications, goals, and current health.
Mounjaro Injection: Weight Loss & Type 2 Diabetes Control in Malaysia
Mounjaro® (tirzepatide) is a prescription injectable treatment that should only be used under proper medical supervision. It is primarily prescribed fro the management of type 2 diabetes, although clinical studies have shown that some patients may also experience meaningful weight reduction during treatment.
At Da Vinci Clinic, suitability for Mounjaro® is assessed individually by our LCP-certified doctors based on your medical history, current medications, health risks and treatment goals. This helps to ensure that treatment is appropriate, safe and tailored to your needs.
In clinical studies, adults using tirzepatide experienced average weight reductions ranging from 12lbs at 5mg dose to 25 lbs at the 15mg dose.
Individual results may vary, and not every treatment is suitable for every patient.
If you are considering Mounjaro or Tirzepatide in Malaysia for weight-management support, a proper doctor consultation is important to determine whether it is suitable for you and how treatment should be monitored. To better understand how tirzepatide may support weight management, read our Complete Guide to Mounjaro for Weight Loss.
Who is suitable for Mounjaro (Tirzepatide)?
- Mounjaro® may be suitable if you:
- Tirzepatide is suitable for individuals who are medically classed as overweight or obese.
- Typically recommended for those with a BMI of 27–30 and above (with additional eligibility criteria).
- Mounjaro is not a quick fix — intended as part of a long-term health approach.
- Aims to reduce health-related risks linked to being overweight or obese.
- Eligibility will be assessed by our doctors to ensure safety and suitability.
Weight Loss & BMI Calculator
*This calculator is illustrative only and not a guarantee. Example uses up to 20% weight loss over 72 weeks with tirzepatide.
Mounjaro Injection Dosage Guide & Price in Malaysia
Mounjaro is usually started at a lower dose before gradually increasing under doctor supervision. This step-by-step approach helps your body adjust to the medication while reducing the risk of side effects such as nausea, vomiting, diarrhoea, constipation, or stomach discomfort.
The cost of Mounjaro in Malaysia varies depending on dosage strength, treatment duration, proper consultation, follow-up reviews, and your personalised plan by our doctors. Most patients start with a lower dosage before gradually increasing under doctor’s supervision, depending on treatment response and side effects.
A doctor consultation is required to assess patient’s body health and medical history, before advising the most suitable treatment plan and estimated price to achieve patient’s weight-goals.
Potential Side Effects of Mounjaro
Common side effects of Mounjaro may include nausea, vomiting, diarrhoea, constipation, reduced appetite, indigestion, stomach discomfort, and fatigue. These effects are often more noticeable when starting treatment or increasing dosage, and may improve as the body adjusts.
However, more serious symptoms require medical attention, such as severe abdominal pain, persistent vomiting, dehydration, allergic reaction, or unusual symptoms.
Treatment should always be monitored and supervised by professional doctors, book a consultation at Da Vinci Clinic
Mounjaro Safety & Medical Guidance
Da Vinci Clinic, Malaysia’s skin clinic and aesthetic clinic offers a comprehensive consultation to our patients before they begin their weight loss treatment.
Our LCP-Certified doctors will assess patient’s full body health, such as:
- BMI ≥30: may be eligible based on BMI alone
- BMI 27–29.9: may be eligible if there is at least one weight-related condition
- BMI <27: usually not eligible for weight-management use
Find out more about Benefits and Side Effects of Mounjaro
What's the Difference: Mounjaro vs Ozempic vs Wegovy?
Whether it’s Mounjaro, Ozempic, or Wegovy, they are all prescription injectable treatments that support weight loss and metabolic health. However, they are not the same medication.
Mounjaro contains tirzepatide, a dual-action active ingredient that activates both GIP and GLP-1 receptors, which are involved in blood sugar regulation, appetite control, and metabolic response. In comparison, Ozempic and Wegovy contain semaglutide, a GLP-1 receptor agonist. Ozempic is primarily prescribed for type 2 diabetes, while Wegovy is indicated for weight management.
The best option depends on your BMI, medical history, blood sugar status, current medications, and doctor’s assessment to determine the best weight loss injection.
Mounjaro® Treatment Details

Medical Consultation
Assessment of your history, current meds, BMI, waistline, and risks → determine suitability for tirzepatide and set weight-loss targets with a doctor-supervised plan.
Initiation & Titration
Start 2.5 mg once weekly for 4 weeks, then increase to 5 mg. If appropriate for weight-loss and tolerability goals, step up gradually (7.5 → 10 → 12.5 → 15 mg) at ~4-week intervals under medical supervision.

How You’ll Use the Pen
Once-weekly subcutaneous injection in abdomen, thigh, or upper arm on the same weekday. We coach you on site rotation, pen handling, and tips to minimise nausea and other mild side effects.
Follow-Ups & Coaching
Regular reviews of weight, BMI, appetite, waistline, and lifestyle. Our team aligns medication with nutrition and movement planning so you stay consistent and see sustainable results.
Why Choose Mounjaro® at Da Vinci Medical?

Award-Winning Clinic
Personalized and Advanced Treatments

Over 20 Years of Experience
Focus on Result-Oriented Solutions

Advanced Technology
FDA-Approved Techniques for Optimal Results

Certified Aesthetic Physicians
MOH LCP-Certified and Well-Trained
Frequently Asked Questions
Mounjaro (Tirzepatide) is approved in Malaysia for type 2 diabetes management and is also used as a medical weight loss injection to help reduce appetite, improve blood sugar, and support safe and sustainable fat loss under doctor's supervision
Yes, Da Vinci Clinic offers Mounjaro® weight loss injection treatments at our clinics in Kuala Lumpur, including our branches in Mid Valley, Bukit Jalil, and Cheras. Patients can book a consultation at the location most convenient for them.
Common side effects of Mounjaro® may include:
- Nausea
- Diarrhea
- Decreased appetite
- Fatigue
These are usually mild and temporary, but patients should always consult a doctor for proper monitoring and safety during treatment.
Mounjaro pens should be stored in the refrigerator (2°C - 8°C) and never frozen. If needed, they can be kept at room temperature below 30°C for up to 21 days.
Always keep the pen in its original carton to protect it from light and use it before the expiration date.
Yes, Mounjaro® (Tirzepatide) is FDA & NPRA-approved, with a proven safety profile for diabetes and weight loss treatment. Common side effects such as nausea or digestive discomfort are usually mild and temporary.
At Da Vinci Clinic, all Mounjaro® treatments are carefully supervised by LCP-certified doctors to ensure patient's safety and effectiveness.
Mounjaro® or Tirzepatide is available in different dose strengths.
It is usually started at 2.5 mg once weekly, then increased gradually depending on your doctor’s assessment, up to a maximum adult dose of 15 mg once weekly. Dose adjustments should only be made under medical supervision.
Mounjaro® may offer greater average weight-loss and blood-sugar benefits than Ozempic® in some patients, but it is not automatically better for everyone.
The right treatment depends on your doctor’s assessment of your health profile, goals, and suitability.
Mounjaro is now available at Da Vinci Clinic.
Consult with our LCP-certified doctors to determine your suitability and receive medically supervised treatment.
This content is for informational purposes only. Mounjaro (tirzepatide) is a prescription medication and not available without consultation. At Da Vinci Clinic, our licensed healthcare professionals can discuss weight management options and determine whether a prescription treatment is appropriate for you.
Get In Touch
Meet Our Doctors
Why Patients Choose Da Vinci Clinic
Discover Beauty & Innovation at Da Vinci Clinic
- [email protected]
- +6010-283 2688
- [email protected]
- +6017-995 2688
- Da Vinci Clinic (Mid Valley KL): 13-2, The Boulevard Offices, Mid Valley City, 59200 Kuala Lumpur
- Da Vinci Clinic (Bukit Jalil) DV Prestige: Bukit Jalil: Bukit Jalil Signatures Shop Office B-2-1 & B-3-1 Pusat Perdagangan Bandar Bukit Jalil Persiaran Jalil 7, 57000, Bukit Jalil, Kuala Lumpur
- Da Vinci Clinic (Cheras): 104, Jalan Cerdas, Taman Connaught, 56000 Kuala Lumpur, Wilayah Persekutuan Kuala Lumpur






